IA
VERA icon

IFP Advisors’s Vera Therapeutics VERA Stock Holding History

IFP Advisors’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$40 – 5291
2026
Q1 		$40 Buy
+1
New +$43 ﹤0.01% 4855
2025
Q4 		– Sell
-6
Closed -$174 – 5046
2025
Q3 		$174 Buy
6
+1
+20% +$23 ﹤0.01% 4424
2025
Q2 		$118 Buy
+5
New +$112 ﹤0.01% 4713
2025
Q1 		– Sell
-1
Closed -$42 – 4644
2024
Q4 		$42 Buy
+1
New +$44 ﹤0.01% 4311

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

IFP Advisors's VERA Position: Q2 2026 in Review

IFP Advisors sold out of Vera Therapeutics (VERA) in Q2 2026, closing a stake of 1 share — an estimated $40 sold.

IFP Advisors first reported a position in VERA in Q4 2024 and held it in 4 quarters. The position peaked at $174 in Q3 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • IFP Advisors reported no remaining Vera Therapeutics position as of Q2 2026 after selling out during the quarter.
  • IFP Advisors sold 1 Vera Therapeutics share in Q2 2026, an estimated $40.
  • IFP Advisors first reported a position in Vera Therapeutics in Q4 2024 and held it in 4 quarters.
  • IFP Advisors's Vera Therapeutics position peaked at $174 in Q3 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.